Delivery Order SPE2DB20D2104-SPE2DB25FNBQS
- Not listed
- The Defense Logistics Agency awarded a $1,137.67 delivery order to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays on March 18, 2025, with completion targeted for March 19, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 21, 2025. This firm fixed price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for military and...
- The Defense Logistics Agency awarded a $2,285.52 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a firm fixed price structure and an ultimate completion date of July 15, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,648.10 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of August 6, 2025. This competitive award utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The delivery will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $2,403.19 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays. The contract, which is not set-aside, was competitively awarded on August 29, 2025, with an ultimate completion date of September 2, 2025. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order operates under firm fixed-price terms and represents a child contract to...
- The Defense Logistics Agency awarded a delivery order valued at $1,126.10 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays. The contract, awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the performing location for this order. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,252.20 delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays, with a completion date of September 10, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems....
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,673.49 on August 13, 2025, for the supply of Valtoco 10 mg nasal sprays. This is a firm fixed price contract with no set-aside designation, executed competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The contract is set to reach...
- The Defense Logistics Agency awarded a delivery order valued at $1,387.22 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays, with an ultimate completion date of September 22, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The contract will be performed at AmerisourceBergen's...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNBQSDelivery Order
The Defense Logistics Agency awarded a $1,128.54 delivery order to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. Valtoco (diazepam) is a prescription nasal spray used for acute seizure management and other neurological indications. AmerisourceBergen's role as a major pharmaceutical distributor positions it to supply critical medications and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill competitive federal procurement requirements across a broad spectrum of pharmaceutical products, ranging from specialty medications to generic drugs, vaccines, and medical supplies supporting military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/25/25 |